Loading clinical trials...
Loading clinical trials...
Open Label Randomized Phase II, Multicentre, Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Concomitant-Boost Accelerated Radiotherapy Followed or Not by a Complementary Treatment With Cetuximab in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Conditions
Interventions
Cetuximab
Locations
18
Spain
Hospital Germans Tries i Pujol
Badalona, Barcelona, Spain
H. del Mar / H. de la Esperanza
Barcelona, Barcelona, Spain
H. de la Santa Creu I Sant Pau
Barcelona, Barcelona, Spain
Institut Catala Oncologia: Hospital Duran y Reynals
L'Hospitalet de Llobregat, Barcelona, Spain
Centro Oncológico Regional de Galicia
A Coruña, Coruña, Spain
H. Josep Trueta (ICO)
Girona, Girona, Spain
Start Date
November 1, 2005
Completion Date
November 1, 2009
Last Updated
October 26, 2006
Lead Sponsor
Trial Form Support S.L.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions